These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 24487517)

  • 1. PET study in a patient with spinocerebellar degeneration before and after long-term administration of thyrotropin releasing hormone.
    Tanji H; Nagasawa H; Hayashi T; Onodera H; Fujiwara T; Itoh M; Ido T; Itoyama Y
    Behav Neurol; 1996; 9(3):171-5. PubMed ID: 24487517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
    Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
    Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
    Waragai M; Ogawara K; Takaya Y; Hayashi M
    Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T; Arakawa R
    J Neurol Sci; 2009 Jun; 281(1-2):93-8. PubMed ID: 19286195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
    J Neuroimaging; 2011 Apr; 21(2):132-7. PubMed ID: 19674246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration.
    Shimizu T; Tsutsumi R; Shimizu K; Tominaga N; Nagai M; Ugawa Y; Nishiyama K; Hanajima R
    J Neurol Sci; 2020 Aug; 415():116927. PubMed ID: 32474221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats.
    Heuer H; Schäfer MK; O'Donnell D; Walker P; Bauer K
    J Comp Neurol; 2000 Dec; 428(2):319-36. PubMed ID: 11064370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
    Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
    Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uncoupling of cerebellar blood flow and metabolism in paraneoplastic cerebellar degeneration: report of a case].
    Tanaka S; Tanaka M; Wada N; Okamoto K; Hirai S; Tanaka K
    Rinsho Shinkeigaku; 1997 Jun; 37(6):514-9. PubMed ID: 9366181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP; Owings J; Hayford JT; Blizzard RM
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical studies of thyrotropin-releasing hormone tartrate (TRH-T) as a direct stimulant to the central nervous system.
    Ogashiwa M; Takeuchi K
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):145-51. PubMed ID: 36357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.
    Bassiri RM; Utiger RD
    J Clin Invest; 1973 Jul; 52(7):1616-9. PubMed ID: 4198107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone.
    Beck-Peccoz P; Amr S; Menezes-Ferreira MM; Faglia G; Weintraub BD
    N Engl J Med; 1985 Apr; 312(17):1085-90. PubMed ID: 2984564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone is not required for thyrotropin secretion in the perinatal rat.
    Theodoropoulos T; Braverman LE; Vagenakis AG
    J Clin Invest; 1979 Apr; 63(4):588-94. PubMed ID: 108290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long loop reflex in spinocerebellar degeneration and motor neuron disease--its changes with TRH therapy.
    Touge T; Takeuchi H; Yamada A; Miki H; Nishioka M
    Electromyogr Clin Neurophysiol; 1990; 30(3):131-40. PubMed ID: 2112456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel thyrotropin-releasing hormone analogs: a patent review.
    Khomane KS; Meena CL; Jain R; Bansal AK
    Expert Opin Ther Pat; 2011 Nov; 21(11):1673-91. PubMed ID: 22017410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography.
    Gilman S; Markel DS; Koeppe RA; Junck L; Kluin KJ; Gebarski SS; Hichwa RD
    Ann Neurol; 1988 Mar; 23(3):223-30. PubMed ID: 3259853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic ethanol or glucose consumption alter TRH content and pyroglutamyl aminopeptidase II activity in rat limbic regions.
    de Gortari P; Cisneros M; Joseph-Bravo P
    Regul Pept; 2005 Apr; 127(1-3):141-50. PubMed ID: 15680480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intranasal administration of thyrotropin-releasing hormone on ataxic gait in staggerer mice.
    Matsui K; Itoh K; Mizumachi M; Kubo H; Goto T; Sato S; Wada K
    Neurosci Lett; 1996 Jul; 212(2):115-8. PubMed ID: 8832652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.